Market Overview: Sprycel is an oral prescription medicine used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It works by blocking certain enzymes called tyrosine kinases in cancer cells, slowing or stopping the growth of cancer cells. Sprycel provides an effective treatment option with minimal side effects for CML and Ph+...
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian